The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dutz, J. P.
Right arrow Articles by Bierer, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dutz, J. P.
Right arrow Articles by Bierer, B. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOSPORIN A

The Journal of Immunology, Vol 150, Issue 7 2591-2598, Copyright © 1993 by American Association of Immunologists


ARTICLES

A role for calcineurin in degranulation of murine cytotoxic T lymphocytes

JP Dutz, DA Fruman, SJ Burakoff and BE Bierer
Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139.

The immunosuppressive drugs cyclosporin A (CsA) and FK506 bind to distinct families of intracellular proteins, cyclophilins, and FK506 binding proteins (FKBP) respectively, termed immunophilins. Immuno- suppressant-immunophilin complexes bind to and inhibit the activity of calcineurin, a calcium-dependent serine/threonine phosphatase. CsA is known to inhibit degranulation in CTL as assessed by N benzyloxylcarbonyl-L-lysine thiobenzyl ester-esterase release assays. We have investigated whether calcineurin phosphatase activity is involved in this degranulation. Both CsA and FK506 are shown to inhibit N benzyloxylcarbonyl-L-lysine thiobenzyl esteresterase release in murine CTL clones induced either by cognate target or by PMA and the calcium ionophore A23187. Inhibition is concentration dependent and is observed at drug concentrations that specifically inhibit cellular calcineurin. The FK506-binding immunophilin FKBP12, as well as calcineurin, are shown to be present in these cells by immunoblotting analysis. Rapamycin, a macrolide antibiotic thought to compete with FK506 for binding to common FKBP receptor sites, antagonizes the effects of FK506 on both degranulation and calcineurin activity. Neither the degranulation nor the effect of the immunosuppressants is affected by the protein synthesis inhibitor cycloheximide. These observations suggest a role for calcineurin in CTL degranulation. Thus, in addition to its previously described role in lymphokine gene activation, calcineurin also appears to be involved in T cell activation processes which do not require protein synthesis.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. J. Grybko, J. P. Bartnik, G. A. Wurth, A. T. Pores-Fernando, and A. Zweifach
Calcineurin Activation Is Only One Calcium-dependent Step in Cytotoxic T Lymphocyte Granule Exocytosis
J. Biol. Chem., June 22, 2007; 282(25): 18009 - 18017.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. T Pores-Fernando, R. A Bauer, G. A Wurth, and A. Zweifach
Exocytic responses of single leukaemic human cytotoxic T lymphocytes stimulated by agents that bypass the T cell receptor
J. Physiol., September 15, 2005; 567(3): 891 - 903.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. F. Fierro, G. A. Wurth, and A. Zweifach
Cross-talk with Ca2+ Influx Does Not Underlie the Role of Extracellular Signal-regulated Kinases in Cytotoxic T Lymphocyte Lytic Granule Exocytosis
J. Biol. Chem., June 11, 2004; 279(24): 25646 - 25652.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. Rusnak and P. Mertz
Calcineurin: Form and Function
Physiol Rev, October 1, 2000; 80(4): 1483 - 1521.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. J. Dengler and J. S. Pober
Human Vascular Endothelial Cells Stimulate Memory But Not Naive CD8+ T Cells to Differentiate into CTL Retaining an Early Activation Phenotype
J. Immunol., May 15, 2000; 164(10): 5146 - 5155.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. G. Murray, J. S. Schechner, D. E. Epperson, P. Sultan, J. M. McNiff, C. C. W. Hughes, M. I. Lorber, P. W. Askenase, and J. S. Pober
Dermal Microvascular Injury in the Human Peripheral Blood Lymphocyte Reconstituted-Severe Combined Immunodeficient (HuPBL-SCID) Mouse/Skin Allograft Model Is T Cell Mediated and Inhibited by a Combination of Cyclosporine and Rapamycin
Am. J. Pathol., August 1, 1998; 153(2): 627 - 638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Haverstick, M. Dicus, M. S. Resnick, J. J. Sando, and L. S. Gray
A Role for Protein Kinase Cbeta I in the Regulation of Ca2+ Entry in Jurkat T Cells
J. Biol. Chem., June 13, 1997; 272(24): 15426 - 15433.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.